Felvizumab
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody | 
| Source | Humanized (from mouse) | 
| Target | RSV | 
| Clinical data | |
| ATC code | 
  | 
| Identifiers | |
| CAS Number | |
| ChemSpider | 
  | 
| UNII | |
| KEGG | |
|   | |
Felvizumab is a humanized monoclonal antibody against respiratory syncytial virus.[1][2]
References
- ↑ "WHO Drug Information" (PDF). Archived from the original (PDF) on February 23, 2012.
 - ↑ Milne GW (2018). "6591: Felvizumab". Drugs synonyms and properties. London: Routledge Revivals. ISBN 978-1-351-78989-9.
 
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.